Cargando…

Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review

BACKGROUND: Facing the global threat of emerging resistance to antibiotics, tigecycline, a novel glycylcycline antibiotic, is developed to against multidrug-resistant pathogens, but not recommended for the treatment of complicated urinary tract infection (cUTI). We performed a summary of the literat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang-Xi, Le, Ke-Jia, Shi, Hong-Yao, Zhang, Zai-Li, Cui, Min, Zhong, Han, Yu, Yue-Tian, Gu, Zhi-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844507/ https://www.ncbi.nlm.nih.gov/pubmed/33532318 http://dx.doi.org/10.21037/tau-20-959

Ejemplares similares

Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India
por: Taneja, Neelam, et al.
Publicado: (2011)

Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
por: Zhong, Han, et al.
Publicado: (2020)

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
por: Tanaseanu, Cristina, et al.
Publicado: (2009)

490 High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
por: Sam, Sharon, et al.
Publicado: (2014)

Identification of tigecycline- and vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infection in Iran
por: Yousefi, M., et al.
Publicado: (2017)

Efficacy and safety of piperacillin–tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum β-lactamase-producing Enterobacteriaceae
por: Zhang, Wei, et al.
Publicado: (2023)

The Clinical Efficacy and Safety of Ertapenem for the Treatment of Complicated Urinary Tract Infections Caused by ESBL-Producing Bacteria in Children
por: Karaaslan, Ayse, et al.
Publicado: (2015)

Current therapeutic options for coronavirus disease 2019 (COVID-19)—lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol
por: Zhang, Zai-Li, et al.
Publicado: (2020)

The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
por: Wang, Jian, et al.
Publicado: (2017)

Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis
por: Gong, Jinhong, et al.
Publicado: (2019)

Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial
por: Chen, Zhangjing, et al.
Publicado: (2010)

Antimicrobial Stewardship in Surgery: A Literature Bibliometric Analysis
por: Liu, Yang-Xi, et al.
Publicado: (2022)

The Efficacy and Safety of Mirabegron for the Treatment of Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Meta-analysis
por: Zhang, Dongxu, et al.
Publicado: (2021)

Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections
por: Townsend, Mary L, et al.
Publicado: (2007)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
por: Britt, Nicholas S., et al.
Publicado: (2014)

Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study
por: Lin, Chuwen, et al.
Publicado: (2023)

Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria
por: Heizmann, W. R., et al.
Publicado: (2014)

The efficacy and safety of intravesical chondroitin sulphate solution in recurrent urinary tract infections
por: Rahnama’i, M. S., et al.
Publicado: (2022)

Complicated urinary tract infection by Trichosporon loubieri
por: Premamalini, T., et al.
Publicado: (2019)

Percutaneous Nephrostomy in Complicated Urinary Tract Infections
por: Mondal, Utsav, et al.
Publicado: (2022)

Diagnostic value of 64-slice spiral computed tomography imaging of the urinary tract during the excretory phase for urinary tract obstruction
por: Zhao, De-Li, et al.
Publicado: (2017)

Acquisition of Tigecycline Resistance by Carbapenem-Resistant Klebsiella pneumoniae Confers Collateral Hypersensitivity to Aminoglycosides
por: Chen, Hua-le, et al.
Publicado: (2021)

Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes: Protocol for a systematic review and meta-analysis
por: Shi, Fang-Hong, et al.
Publicado: (2018)

A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China
por: Chen, Yijian, et al.
Publicado: (2018)

Epidemiology, Microbiology and Outcomes of Catheter-Associated Urinary Tract Infection and Complicated Urinary Tract Infection in the USA
por: Merchant, Sanjay, et al.
Publicado: (2017)

Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021)

Efficacy and safety of muscarinic antagonists as add-on therapy for male lower urinary tract symptoms
por: Li, Jinhong, et al.
Publicado: (2014)

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Shi, Fang-Hong, et al.
Publicado: (2018)

Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection
por: Yu, Meiling, et al.
Publicado: (2023)

666. Efficacy and Safety of Cefiderocol According to Renal Impairment in Patients With Complicated Urinary Tract Infection (cUTI) in a Phase 2 Study
por: Portsmouth, Simon, et al.
Publicado: (2019)

Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysis
por: Ezure, Yukiko, et al.
Publicado: (2020)

Bacillus Coli Infection of Urinary Tract Complicating Pregnancy
por: Burnett, E. Napier
Publicado: (1910)

Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019)

Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units
por: Bai, Xiang-rong, et al.
Publicado: (2023)

Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients
por: Sun, Li-Hua, et al.
Publicado: (2022)

Emergence of tigecycline resistance in Escherichia coli co-producing MCR-1 and NDM-5 during tigecycline salvage treatment
por: Wang, Qian, et al.
Publicado: (2018)

Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales
por: Bouiller, Kévin, et al.
Publicado: (2022)

CSE-1034 versus Ceftriaxone: Efficacy and Safety Analysis from a Randomized, Open-labeled Phase III Study in Complicated Urinary Tract Infections
por: Chaudhary, Manu, et al.
Publicado: (2018)

Genetic diversity and characteristics of high-level tigecycline resistance Tet(X) in Acinetobacter species
por: Chen, Chong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mboi0mnpq1okla5qf1fc0b9gu3